Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Sulfadiazine, silver [USAN:USP]
RN: 22199-08-2
UNII: W46JY43EJR
InChIKey: UEJSSZHHYBHCEL-UHFFFAOYSA-N

Note

  • Antibacterial used topically in burn therapy.

Molecular Formulas

  • C10-H10-N4-O2-S.Ag
  • C10-H9-Ag-N4-O2-S

Molecular Weight

  • 357.1431
 

Classification Codes

  • Anti-Infective Agents
  • Anti-Infective Agents, Local
  • Anti-Infective, Topical
  • Drug / Therapeutic Agent
  • Human Data
  • Mutation Data
  • Reproductive Effect
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Silver sulfadiazine
  • Sulfadiazine silver salt
  • Sulfadiazine, silver [USAN:USP]

MeSH Heading

  • Silver sulfadiazine

Synonyms

  • 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide silver salt
  • Dermazin
  • Dermazine
  • EINECS 244-834-5
  • Flamazine
  • Geben
  • N(sup 1)-2-Pyrimidinylsulfanilamide monosilver(1+) salt
  • N1-2-Pyrimidinylsulfanilamide monosilver(1+) salt
  • NSC 625324
  • Silbertone
  • Silvadene
  • Silver sulfadiazine
  • Silver sulphadiazine
  • SSD
  • SSD AF
  • Sulfadiazin silber
  • Sulfadiazin, silbersalz
  • Sulfadiazine silver
  • Sulfadiazine silver salt
  • Sulfadiazine, Silver
  • Sulfolex
  • Thermazene
  • UNII-W46JY43EJR

Systematic Names

  • (4-Amino-N-pyrimidin-2-ylbenzenesulphonamidato-NN,O1)silver
  • Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, monosilver(1+) salt
  • Silver, (4-amino-N-2-pyrimidinylbenzenesulfonamidato-NN,O1)-
  • Sulfanilamide, N(sup 1)-2-pyrimidinyl-, monosilver(1+) salt

Mixture Name

  • SSD

Registry Numbers

CAS Registry Number

  • 22199-08-2

FDA UNII

  • W46JY43EJR

System Generated Number

  • 0022199082

Molecular Formulas

Molecular Formulas

  • C10-H10-N4-O2-S.Ag
  • C10-H9-Ag-N4-O2-S

Molecular Formula Fragments

  • Ag
  • C10-H10-N4-O2-S
  • COMPONENT

Structure Descriptors

InChI

InChI=1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1

InChIKey

UEJSSZHHYBHCEL-UHFFFAOYSA-N

Smiles

[Ag+].Nc1ccc(cc1)S(=O)(=O)[N-]c2ncccn2

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo skin 536mg/kg/21W- (536mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) Lancet. Vol. 340, Pg. 126, 1992.
mouse LDLo intraperitoneal 550mg/kg (550mg/kg)   United States Patent Document. Vol. #4020150,
mouse LDLo oral > 10gm/kg (10000mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 14, Pg. 2850, 1980.
mouse LDLo oral > 10gm/kg (10000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)		 Kiso to Rinsho. Clinical Report. Vol. 14, Pg. 2850, 1980.
mouse LDLo subcutaneous > 10gm/kg (10000mg/kg) BLOOD: CHANGES IN SPLEEN

LIVER: OTHER CHANGES		 Kiso to Rinsho. Clinical Report. Vol. 14, Pg. 2850, 1980.
rat LD50 intraperitoneal 126mg/kg (126mg/kg) BLOOD: CHANGES IN SPLEEN

LIVER: OTHER CHANGES

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"		 Kiso to Rinsho. Clinical Report. Vol. 14, Pg. 2850, 1980.
rat LD50 oral > 10gm/kg (10000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 637, 1982.
rat LD50 unreported 160mg/kg (160mg/kg)   United States Patent Document. Vol. #4535078,
rat LDLo subcutaneous > 10gm/kg (10000mg/kg) LIVER: OTHER CHANGES

BLOOD: CHANGES IN SPLEEN		 Kiso to Rinsho. Clinical Report. Vol. 14, Pg. 2850, 1980.